4.4 Review

Tetraploidy, aneuploidy and cancer

Journal

CURRENT OPINION IN GENETICS & DEVELOPMENT
Volume 17, Issue 2, Pages 157-162

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2007.02.011

Keywords

-

Funding

  1. NCI NIH HHS [R01CA98537] Funding Source: Medline
  2. NIGMS NIH HHS [5T32GM008704] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [R01CA098537] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Aneuploidy is one of the most obvious differences between normal and cancer cells. However, there remains debate over how aneuploid cells arise and whether or not they are a cause or consequence of tumorigenesis. One proposed route to aneuploid cancer cells is through an unstable tetraploid intermediate. Supporting this idea, recent studies demonstrate that tetraploidy promotes chromosomal aberrations and tumorigenesis in vivo. These tetraploid cells can arise by a variety of mechanisms, including mitotic slippage, cytokinesis failure, and viral-induced cell fusion. Furthermore, new studies suggest that there might not be a ploidy-sensing checkpoint that permanently blocks the proliferation of tetraploid cells. Therefore, abnormal division of tetraploid cells might facilitate genetic changes that lead to aneuploid cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available